Uterine Cancer Screening, Diagnosis, and Treatment

There are more than 63,000 new cases of uterine and endometrial cancer each year in the United States, up from approximately 41,000 when the first edition of Uterine Cancer was published in 2009. A book focusing on these cancers was timely, with emergent sophistication in diagnosis increasingly impa...

Full description

Bibliographic Details
Other Authors: Muggia, Franco (Editor), Santin, Alessandro D. (Editor), Oliva, Esther (Editor)
Format: eBook
Language:English
Published: Cham Springer International Publishing 2018, 2018
Edition:2nd ed. 2018
Series:Current Clinical Oncology
Subjects:
Online Access:
Collection: Springer eBooks 2005- - Collection details see MPG.ReNa
LEADER 03180nmm a2200325 u 4500
001 EB001854559
003 EBX01000000000000001018861
005 00000000000000.0
007 cr|||||||||||||||||||||
008 181201 ||| eng
020 |a 9783319472690 
100 1 |a Muggia, Franco  |e [editor] 
245 0 0 |a Uterine Cancer  |h Elektronische Ressource  |b Screening, Diagnosis, and Treatment  |c edited by Franco Muggia, Alessandro D. Santin, Esther Oliva 
250 |a 2nd ed. 2018 
260 |a Cham  |b Springer International Publishing  |c 2018, 2018 
300 |a XII, 278 p. 70 illus., 42 illus. in color  |b online resource 
505 0 |a The Essential Epidemiology of Cancer of the Endometrium -- Endometrial Cancer: Screening, Diagnosis, and Surgical Staging -- Imaging in the Diagnosis and Treatment of Endometrial Cancer -- Uterine Cancer: Pathology -- Molecular Pathology and Cytogenetics of Endometrial Carcinoma, Carcinosarcoma, and Uterine Sarcomas -- Prognostic Factors in Uterine Cancer -- Primary Hormonal Therapy of Endometrial Cancer -- Early-Stage Endometrial Cancer: Surgery -- Early-Stage Endometrial Cancer: Radiation—Less May Be More -- Therapeutic Modalities in Early-Stage Uterine Papillary Serous Carcinomas, Carcinosarcomas, Clear-Cell and Mixed Histology Carcinomas: Treatment of Choice Is Combined Chemotherapy and Radiation -- Treatment of Advanced and Recurrent Carcinoma: Chemotherapy -- Treatment for Advanced and Recurrent Carcinoma: Combined Modalities -- Management of Uterine Sarcomas -- Future Directions and New Targets in Endometrial Cancer 
653 |a Gynecology 
653 |a Radiology 
653 |a Gynecology  
653 |a Oncology 
700 1 |a Santin, Alessandro D.  |e [editor] 
700 1 |a Oliva, Esther  |e [editor] 
041 0 7 |a eng  |2 ISO 639-2 
989 |b Springer  |a Springer eBooks 2005- 
490 0 |a Current Clinical Oncology 
028 5 0 |a 10.1007/978-3-319-47269-0 
856 4 0 |u https://doi.org/10.1007/978-3-319-47269-0?nosfx=y  |x Verlag  |3 Volltext 
082 0 |a 616.994 
520 |a There are more than 63,000 new cases of uterine and endometrial cancer each year in the United States, up from approximately 41,000 when the first edition of Uterine Cancer was published in 2009. A book focusing on these cancers was timely, with emergent sophistication in diagnosis increasingly impacting clinical decision-making. However, five years later, the need for an updated book on this topic is even stronger as oncologists recognize opportunities to impact the outcome on women that are increasingly diagnosed with these malignancies. Uterine Cancer: Screening, Diagnosis, and Treatment, Second Edition, part of the Current Clinical Oncology series, enhances the awareness on this somewhat neglected area of therapeutics, helping to integrate targeted therapies into the management of women with uterine cancer. Written by experts in the field in a highly practical and comprehensive manner, it is a must-have for all gynecological residents and fellows, as well as gynecological oncologists, medical oncologists, radiation oncologists, and family practice doctors who wish to provide their patients with the best possible care